Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-up.

导出 LinkOut

翻译打印收藏纠错

第一作者： Arata,Nakajima

第一单位： Departments of Orthopaedics, Toho University Sakura Medical Center, Chiba, Japan.;Departments of Rheumatology, Toho University Sakura Medical Center, Chiba, Japan.

作者： Arata,Nakajima ^[1] ; Keiichiro,Terayama ^[2] ; Masato,Sonobe ^[3] ; Yasuchika,Aoki ^[4] ; Hiroshi,Takahashi ^[3] ; Yorikazu,Akatsu ^[3] ; Shinji,Taniguchi ^[3] ; Manabu,Yamada ^[3] ; Ayako,Kubota ^[5] ; Koichi,Nakagawa ^[3]

作者单位： Departments of Orthopaedics, Toho University Sakura Medical Center, Chiba, Japan.;Departments of Rheumatology, Toho University Sakura Medical Center, Chiba, Japan. ^[1] Departments of Rehabilitation, Toho University Sakura Medical Center, Chiba, Japan. ^[2] Departments of Orthopaedics, Toho University Sakura Medical Center, Chiba, Japan. ^[3] Department of General Medical Sciences, Graduate School of Medicine, Chiba University, Chiba, Japan.;Department of Orthopaedic Surgery, Eastern Chiba Medical Center, Chiba, Japan. ^[4] Department of Orthopaedics, Toho University Omori Medical Center, Tokyo, Japan. ^[5]

关键词 biological disease-modifying antirheumatic drugs (bDMARDs)large joints predictive factors radiographic progression of damage rheumatoid arthritis